NovelStem International Corp. (NSTM)
| Previous Close | 0.2200 |
| Open | 0.2200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2200 - 0.2200 |
| 52 Week Range | 0.0300 - 0.3300 |
| Volume | |
| Avg. Volume | 22,059 |
| Market Cap | 4.981M |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 1.16 |
| EPS (TTM) | 0.1900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr 02, 2018 |
| 1y Target Est | N/A |
- Newsfile
NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltd
NewStem is the only company worldwide to develop therapeutics and diagnostics products based on haploid human embryonic stem cell research Jerusalem, Israel and Boca Raton, Florida--(Newsfile Corp. - April 11, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem Ltd., today announced NewStem's filing of a pre-submission to the FDA for a De Novo Request and an in vitro diagno
- Newsfile
NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset
Boca Raton, Florida--(Newsfile Corp. - February 15, 2022) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned, Israel-based NewStem, Ltd., today reviewed progress regarding ongoing efforts to maximize shareholder value from its legacy 50% ownership in Netco Partners, which owns the Net Force publishing and entertainment franchise.NovelStem Chairman, Jan Loeb, commented, "We have initiated an arbitrati
- Newsfile
NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator
Boca Raton, Florida and Jerusalem, Israel--(Newsfile Corp. - September 20, 2021) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned Israel-based, NewStem, Ltd., announced that NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. Illumina Accelerator is a company creation engine that focuses on partnering with and building companies with unique
